GREEN_CROSS_MEDICO_LIMITE - Accounts


Company Registration No. SC159637 (Scotland)
GREEN CROSS MEDICO LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2019
PAGES FOR FILING WITH REGISTRAR
GREEN CROSS MEDICO LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 7
GREEN CROSS MEDICO LIMITED
BALANCE SHEET
AS AT
31 DECEMBER 2019
31 December 2019
- 1 -
2019
2018
Notes
£
£
£
£
Fixed assets
Intangible assets
3
204,917
157,163
Tangible assets
4
601
1,453
205,518
158,616
Current assets
Stocks
43,894
60,763
Debtors
5
38,656
49,592
Cash at bank and in hand
1,712
966
84,262
111,321
Creditors: amounts falling due within one year
6
(2,707,132)
(2,521,575)
Net current liabilities
(2,622,870)
(2,410,254)
Total assets less current liabilities
(2,417,352)
(2,251,638)
Capital and reserves
Called up share capital
8
2,305,463
2,305,463
Share premium account
3,832,000
3,832,000
Profit and loss reserves
(8,554,815)
(8,389,101)
Total equity
(2,417,352)
(2,251,638)

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 December 2019 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

GREEN CROSS MEDICO LIMITED
BALANCE SHEET (CONTINUED)
AS AT
31 DECEMBER 2019
31 December 2019
2019
2018
Notes
£
£
£
£
- 2 -
The financial statements were approved by the board of directors and authorised for issue on 6 October 2020 and are signed on its behalf by:
Mr G Benedetti
Director
Company Registration No. SC159637
GREEN CROSS MEDICO LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2019
- 3 -
1
Accounting policies
Company information

Green Cross Medico Limited is a private company limited by shares incorporated in Scotland. The registered office is 10 Bothwell Bridge Business Park, Bothwell Road, Hamilton, Lanarkshire, Scotland, ML3 0FD.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention.

1.2
Going concern

The company has net liabilities of £2,379,133 at the balance sheet date. The directors continue to support the company by way of loan. The directors intend to continue this support for not less than 12 months from the balance sheet date.true

 

In common with most businesses the company is facing potential issues in respect of the COVID-19 pandemic. This is an ongoing situation and the company is adopting a strategy to manage the ever-changing situation as effectively as possible.

 

The directors are satisfied that these events do not affect the company's ability to continue as a going concern and this basis is appropriate for the preparation of the accounts.

 

 

1.3
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

 

1.4
Research and development expenditure

Research expenditure is written off against profits in the year in which it is incurred. Identifiable development expenditure is capitalised to the extent that the technical, commercial and financial feasibility can be demonstrated.

1.5
Intangible fixed assets other than goodwill

Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Development costs
are amortised evenly over their estimated useful life of 10 years
1.6
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

GREEN CROSS MEDICO LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2019
1
Accounting policies
(Continued)
- 4 -

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Computers
25% on cost

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.7
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any).

1.8
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

1.9
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.10
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

GREEN CROSS MEDICO LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2019
1
Accounting policies
(Continued)
- 5 -
1.11
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

1.12
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.13
Government grants

Government grants are recognised at the fair value of the asset received or receivable when there is reasonable assurance that the grant conditions will be met and the grants will be received.

 

A grant that specifies performance conditions is recognised in income when the performance conditions are met. Where a grant does not specify performance conditions it is recognised in income when the proceeds are received or receivable. A grant received before the recognition criteria are satisfied is recognised as a liability.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was 3 (2018 - 4).

2019
2018
Number
Number
Total
3
4
3
Intangible fixed assets
Other
£
Cost
At 1 January 2019
157,163
Additions
70,523
At 31 December 2019
227,686
Amortisation and impairment
At 1 January 2019
-
Amortisation charged for the year
22,769
At 31 December 2019
22,769
Carrying amount
At 31 December 2019
204,917
At 31 December 2018
157,163
GREEN CROSS MEDICO LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2019
- 6 -
4
Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 January 2019 and 31 December 2019
3,409
Depreciation and impairment
At 1 January 2019
1,956
Depreciation charged in the year
852
At 31 December 2019
2,808
Carrying amount
At 31 December 2019
601
At 31 December 2018
1,453
5
Debtors
2019
2018
Amounts falling due within one year:
£
£
Trade debtors
1,308
2,633
Other debtors
37,348
46,959
38,656
49,592
6
Creditors: amounts falling due within one year
2019
2018
£
£
Trade creditors
68,088
21,229
Taxation and social security
4,350
3,993
Other creditors
2,634,694
2,496,353
2,707,132
2,521,575
7
Secured debts

Clydesdale Bank plc hold a floating charge over the assets of the company.

GREEN CROSS MEDICO LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2019
- 7 -
8
Called up share capital
2019
2018
£
£
Ordinary share capital
Issued and fully paid
2,305,463 A Ordinary shares of £1 each
2,305,463
2,305,463
9
Events after the reporting date

In common with most businesses the company is facing potential issues in respect of the COVID-19 pandemic. This is an ongoing situation and the company is adopting a strategy to manage the ever-changing situation as effectively as possible.

 

10
Related party transactions

The following amounts were outstanding at the reporting end date:

2019
2018
Amounts due to related parties
£
£
Amounts due to directors
2,624,140
2,487,246

The loan is unsecured, interest free and no fixed terms of repayment.

2019-12-312019-01-01false06 October 2020CCH SoftwareCCH Accounts Production 2020.200No description of principal activityMr G BenedettiMr S PuriMrs S B JackMr K WilsonMr G BenedettiSC1596372019-01-012019-12-31SC1596372019-12-31SC159637core:IntangibleAssetsOtherThanGoodwill2019-12-31SC159637core:IntangibleAssetsOtherThanGoodwill2018-12-31SC1596372018-01-012018-12-31SC1596372018-12-31SC159637core:OtherPropertyPlantEquipment2019-12-31SC159637core:OtherPropertyPlantEquipment2018-12-31SC159637core:CurrentFinancialInstrumentscore:WithinOneYear2019-12-31SC159637core:CurrentFinancialInstrumentscore:WithinOneYear2018-12-31SC159637core:ShareCapital2019-12-31SC159637core:ShareCapital2018-12-31SC159637core:SharePremium2019-12-31SC159637core:SharePremium2018-12-31SC159637core:RetainedEarningsAccumulatedLosses2019-12-31SC159637core:RetainedEarningsAccumulatedLosses2018-12-31SC159637core:ShareCapitalOrdinaryShares2019-12-31SC159637core:ShareCapitalOrdinaryShares2018-12-31SC159637bus:CompanySecretaryDirector12019-01-012019-12-31SC159637core:IntangibleAssetsOtherThanGoodwill2019-01-012019-12-31SC159637core:DevelopmentCostsCapitalisedDevelopmentExpenditure2019-01-012019-12-31SC159637core:ComputerEquipment2019-01-012019-12-31SC159637core:IntangibleAssetsOtherThanGoodwill2018-12-31SC159637core:OtherPropertyPlantEquipment2018-12-31SC159637core:OtherPropertyPlantEquipment2019-01-012019-12-31SC159637core:CurrentFinancialInstruments2019-12-31SC159637core:CurrentFinancialInstruments2018-12-31SC159637core:WithinOneYear2019-12-31SC159637core:WithinOneYear2018-12-31SC159637bus:PrivateLimitedCompanyLtd2019-01-012019-12-31SC159637bus:SmallCompaniesRegimeForAccounts2019-01-012019-12-31SC159637bus:FRS1022019-01-012019-12-31SC159637bus:AuditExemptWithAccountantsReport2019-01-012019-12-31SC159637bus:Director12019-01-012019-12-31SC159637bus:Director22019-01-012019-12-31SC159637bus:Director32019-01-012019-12-31SC159637bus:Director42019-01-012019-12-31SC159637bus:CompanySecretary12019-01-012019-12-31SC159637bus:FullAccounts2019-01-012019-12-31xbrli:purexbrli:sharesiso4217:GBP